Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and HIV-associated immune activation
PACTR201301000445375Completed
- Sponsor
- Damalie Nakanjako
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of atorvastatin in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Damalie Nakanjako. Primary endpoint: Reduction in immune activation levels. Started Dec 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201301000445375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201301000445375.